If you haven`t bought OCGN when they released their Covid vaccine:
Then analyzing the options chain and the chart patterns of OCGN Ocugen prior to the earnings report this week,
I would consider purchasing the 1.50usd strike price Calls with
an expiration date of 2024-5-17,
for a premium of approximately $0.22.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Then analyzing the options chain and the chart patterns of OCGN Ocugen prior to the earnings report this week,
I would consider purchasing the 1.50usd strike price Calls with
an expiration date of 2024-5-17,
for a premium of approximately $0.22.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Trade fermée: cible de profit atteinte
OCGN traded at $2.02 after earnings, at expiration, and the Calls went up from $0.22 (when I wrote this article) to $0.41 at the close of the day (even higher intraday), for a decent 85% gain!
DAILY PRIVATE HIGH-CONVICTION OPTIONS SIGNALS: patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Publications connexes
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
DAILY PRIVATE HIGH-CONVICTION OPTIONS SIGNALS: patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Publications connexes
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.